4
Changes in Ownership
Mineralys Therapeutics, Inc. Filed Acc 0001933414-25-000060
Chief Medical Officer acquired 6,349 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Rodman David Malcom Chief Medical Officer | 2025-05-12 | Option exercise 10b5-1 | +6,349 | $1.08 | $6,857 | 118,035 | D |
| Derivatives | |||||||
| Rodman David Malcom Chief Medical Officer | 2025-05-12 | Option exercise · Stock Option 10b5-1 | −6,349 | 101,577 | D | ||
Loading xslF345X05/wk-form4_1747184222.xml…